Dementia with Lewy bodies (DLB) is thought to be the second commonest cause of neurodegenerative dementia in older people, accounting 15 to 25% cases at autopsy. However, to date there are no reliable methods of instrumental and laboratory diagnosis of this disease while its treatment is based on reducing the symptoms. The drug X has been shown to have neuroprotective effects in neurodegenerative diseases. Therefore, we aimed to clarify the medicinal effectiveness of drug X through manganese-enhanced magnetic resonance imaging (MEMRI). Our results indicated that drug X may have clinical potential in the treatment of DLB.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords